News Daily News Now You See It: Imaging Helps Lower CVD Risk Burden in Primary Prevention Michael O'Riordan December 10, 2018
News Daily News SYNTAX Score Should Not Guide Revascularization Strategy in FREEDOM-Like Patients Michael O'Riordan December 04, 2018
News Daily News PIONEER 6: Oral Semaglutide Passes Test in Cardiovascular Outcomes Study Michael O'Riordan November 23, 2018
News Conference News AHA 2018 EMPA-HEART Offers Mechanistic Clues for Empagliflozin’s Cardiac Benefits Michael O'Riordan November 16, 2018
News Conference News AHA 2018 Sit Less, Move More: New Physical Activity Guidelines Stress Movement at All Ages Michael O'Riordan November 12, 2018
News Conference News AHA 2018 DECLARE-TIMI 58 Supports HF Benefit of SGLT2 Inhibitors Todd Neale November 10, 2018
News Daily News Big Fitness Equals Big Survival Benefit, New Study Shows Michael O'Riordan October 22, 2018
News Daily News Bariatric Surgery Reduces Hard CVD Events in Obese Patients With Type 2 Diabetes Michael O'Riordan October 18, 2018
News Conference News ESC 2018 ASCEND: Aspirin Doesn’t Look Good for Primary CV Prevention in Diabetic Patients Todd Neale August 26, 2018
News Daily News In Type 2 Diabetes, Five Risk Factor Targets Keep MI, Stroke, and Death in Check Caitlin E. Cox August 15, 2018
News Daily News SGLT2 Inhibitors Work in Type 2 Diabetes Across Levels of CV Risk, Renal Function Todd Neale July 02, 2018
News Daily News Reduction in CVD Events, Even Mortality, in Patients With Diabetes Who Adopt a Healthier Lifestyle Michael O'Riordan June 18, 2018
News Conference News EAS 2018 EAS Consensus Document Examines Safety of Statins Beyond Muscle Symptoms Yael L. Maxwell May 11, 2018
News Daily News Obesity Robs People of CVD-Free Years and Ups the Risk of Dying Young Michael O'Riordan March 02, 2018